Restless Legs Syndrome across the Lifespan: Symptoms, Pathophysiology, Management and Daily Life Impact of the Different Patterns of Disease Presentation

被引:42
作者
Didato, Giuseppe [1 ]
Di Giacomo, Roberta [1 ]
Rosa, Giuseppa Jolanda [1 ,2 ]
Dominese, Ambra [1 ]
de Curtis, Marco [1 ]
Lanteri, Paola [3 ]
机构
[1] Fdn IRCCS Carlo Besta Neurol Inst, Clin & Expt Epileptol & Sleep Disorders Unit, Via Celoria 11, I-20133 Milan, Italy
[2] Univ Hosp Ferrara, Neurol Unit, I-44100 Ferrara, Italy
[3] Fdn IRCCS Carlo Besta Neurol Inst, Neurophysiopathol Unit, I-20133 Milan, Italy
关键词
restless legs syndrome; sleep; lifespan; age; quality of life; workplace; gender; genetic; environment; PERIODIC LIMB MOVEMENTS; WILLIS-EKBOM DISEASE; DIAGNOSTIC-CRITERIA; DOPAMINERGIC AUGMENTATION; IRON-DEFICIENCY; SPINAL-CORD; TASK-FORCE; SLEEP; ASSOCIATION; IRLSSG;
D O I
10.3390/ijerph17103658
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Restless legs syndrome is a common but still underdiagnosed neurologic disorder, characterized by peculiar symptoms typically occurring in the evening and at night, and resulting in sleep disruption and daily functioning impairment. This disease can affect subjects of all age ranges and of both sexes, manifesting itself with a broad spectrum of severity and deserving special attention in certain patient categories, in order to achieve a correct diagnosis and an effective treatment. The diagnosis of restless legs syndrome can be challenging in some patients, especially children and elderly people, and an effective treatment might be far from being easy to achieve after some years of drug therapy, notably when dopaminergic agents are used. Moreover, the pathophysiology of this disorder offers an interesting example of interaction between genetics and the environment, considering strong iron metabolism involvement and its interaction with recognized individual genetic factors. Therefore, this syndrome allows clinicians to verify how lifespan and time can modify diagnosis and treatment of a neurological disorder.
引用
收藏
页数:18
相关论文
共 80 条
  • [1] Effects of Sleep Duration on Cardiovascular Events
    Ahmad, Adeel
    Didia, S. Claudia
    [J]. CURRENT CARDIOLOGY REPORTS, 2020, 22 (04)
  • [2] Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report
    Allen, Richard P.
    Picchietti, Daniel L.
    Auerbach, Michael
    Cho, Yong Won
    Connor, James R.
    Earley, Christopher J.
    Garcia-Borreguero, Diego
    Kotagal, Suresh
    Manconi, Mauro
    Ondo, William
    Ulfberg, Jan
    Winkelman, John W.
    [J]. SLEEP MEDICINE, 2018, 41 : 27 - 44
  • [3] Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology
    Allen, Richard P.
    [J]. SLEEP MEDICINE CLINICS, 2015, 10 (03) : 207 - +
  • [4] Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria - history, rationale, description, and significance
    Allen, Richard P.
    Picchietti, Daniel L.
    Garcia-Borreguero, Diego
    Ondo, William G.
    Walters, Arthur S.
    Winkelman, John W.
    Zucconi, Marco
    Ferri, Raffaele
    Trenkwalder, Claudia
    Lee, Hochang B.
    [J]. SLEEP MEDICINE, 2014, 15 (08) : 860 - 873
  • [5] Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis
    Allen, Richard P.
    Connor, James R.
    Hyland, Keith
    Earley, Christopher J.
    [J]. SLEEP MEDICINE, 2009, 10 (01) : 123 - 128
  • [6] Restless legs syndrome prevalence and impact - REST general population study
    Allen, RP
    Walters, AS
    Montplaisir, J
    Hening, W
    Myers, A
    Bell, TJ
    Ferini-Strambi, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) : 1286 - 1292
  • [7] Augmentation of the restless legs syndrome with carbidopa/levodopa
    Allen, RP
    Earley, CJ
    [J]. SLEEP, 1996, 19 (03) : 205 - 213
  • [8] American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S, P282
  • [9] Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome
    Anguelova, Galia V.
    Vlak, Monique H. M.
    Kurvers, Arthur G. Y.
    Rijsman, Roselyne M.
    [J]. SLEEP MEDICINE CLINICS, 2018, 13 (02) : 219 - +
  • [10] Nocturnal eating is part of the clinical spectrum of restless legs syndrome and an underestimated risk factor for increased body mass index
    Antelmi, Elena
    Vinai, Piergiuseppe
    Pizza, Fabio
    Marcatelli, Marco
    Speciale, Maurizio
    Provini, Federica
    [J]. SLEEP MEDICINE, 2014, 15 (02) : 168 - 172